Načítá se...
Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents
OBJECTIVES: Anaemia is the most common side effect associated with ribavirin (RBV). This study intended to assess its incidence and determine its predictive factors in patients with hepatitis C virus on RBV plus direct-acting antiviral agents (DAAs). METHODS: A retrospective study of patients receiv...
Uloženo v:
| Vydáno v: | Eur J Hosp Pharm |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
European Journal of Hospital Pharmacy
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452397/ https://ncbi.nlm.nih.gov/pubmed/31157007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2017-001277 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|